Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Y C Heng

Showing results (11-20 of 214) with videos related to

Pageof 22
Sort By:
The Canadian Journal of Urology|December 26, 2006
Prednisone monotherapy in asymptomatic hormone refractory prostate cancerDaniel Y C Heng, Kim N Chi
Current Oncology Reports|December 25, 2012
Programmed death 1 pathway inhibition in metastatic renal cell cancer and prostate cancerPatricia A Tang, Daniel Y C Heng
European Urology|April 20, 2023
Reply to Binghao Zhao, Hao Xing, and Wenbin Ma's Letter to the Editor re: Matthew S. Ernst, Vishal Navani, J. Connor Wells, et al. Outcomes for International Metastatic Renal Cell Carcinoma Database Consortium Prognostic Groups in Contemporary First-line Combination Therapies for Metastatic Renal Cell Carcinoma. Eur Urol. 2023;84:109-116Matthew S Ernst, Daniel Y C Heng
Current Cancer Drug Targets|December 17, 2008
Anti-angiogenic targets in the treatment of advanced renal cell carcinomaDaniel Y C Heng, Ronald M Bukowski
Critical Reviews in Clinical Laboratory Sciences|January 24, 2014
Management of metastatic kidney cancer in the era of personalized medicineJose G Monzon, Daniel Y C Heng
Journal of the National Comprehensive Cancer Network : JNCCN|June 27, 2009
Non-clear cell renal cancer: features and medical managementDaniel Y C Heng, Toni K Choueiri
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|January 24, 2014
The evolving landscape of metastatic renal cell carcinomaDaniel Y C Heng, Toni K Choueiri
Oncology Reviews|July 30, 2016
Contemporary Treatment of Metastatic Renal Cell CarcinomaIgor Stukalin, Nimira Alimohamed, Daniel Y C Heng
Urologic Oncology|September 12, 2015
The use of prognostic factors in metastatic renal cell carcinomaHaoran Li, Haider Samawi, Daniel Y C Heng
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 30, 2018
Prognostication in Kidney Cancer: Recent Advances and Future DirectionsJeffrey Graham, Shaan Dudani, Daniel Y C Heng
Pageof 22

Showing results (11-20 of 214) with videos related to

Sort By:
Pageof 22
The Canadian Journal of Urology|December 26, 2006
Prednisone monotherapy in asymptomatic hormone refractory prostate cancerDaniel Y C Heng, Kim N Chi
Current Oncology Reports|December 25, 2012
Programmed death 1 pathway inhibition in metastatic renal cell cancer and prostate cancerPatricia A Tang, Daniel Y C Heng
European Urology|April 20, 2023
Reply to Binghao Zhao, Hao Xing, and Wenbin Ma's Letter to the Editor re: Matthew S. Ernst, Vishal Navani, J. Connor Wells, et al. Outcomes for International Metastatic Renal Cell Carcinoma Database Consortium Prognostic Groups in Contemporary First-line Combination Therapies for Metastatic Renal Cell Carcinoma. Eur Urol. 2023;84:109-116Matthew S Ernst, Daniel Y C Heng
Current Cancer Drug Targets|December 17, 2008
Anti-angiogenic targets in the treatment of advanced renal cell carcinomaDaniel Y C Heng, Ronald M Bukowski
Critical Reviews in Clinical Laboratory Sciences|January 24, 2014
Management of metastatic kidney cancer in the era of personalized medicineJose G Monzon, Daniel Y C Heng
Journal of the National Comprehensive Cancer Network : JNCCN|June 27, 2009
Non-clear cell renal cancer: features and medical managementDaniel Y C Heng, Toni K Choueiri
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|January 24, 2014
The evolving landscape of metastatic renal cell carcinomaDaniel Y C Heng, Toni K Choueiri
Oncology Reviews|July 30, 2016
Contemporary Treatment of Metastatic Renal Cell CarcinomaIgor Stukalin, Nimira Alimohamed, Daniel Y C Heng
Urologic Oncology|September 12, 2015
The use of prognostic factors in metastatic renal cell carcinomaHaoran Li, Haider Samawi, Daniel Y C Heng
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 30, 2018
Prognostication in Kidney Cancer: Recent Advances and Future DirectionsJeffrey Graham, Shaan Dudani, Daniel Y C Heng
Pageof 22